Literature DB >> 21622023

HIV-1 genetic diversity and drug resistance among treatment naïve patients from Southern Brazil: an association of HIV-1 subtypes with exposure categories.

Tiago Gräf1, Caroline P B Passaes, Luis G E Ferreira, Edmundo C Grisard, Mariza G Morgado, Gonzalo Bello, Aguinaldo R Pinto.   

Abstract

BACKGROUND: The AIDS epidemic in Southern Brazil has unique features, showing co-circulation of HIV-1 subtypes C, B and recombinant forms. Florianópolis has the second highest AIDS incidence among Brazilian capitals, but limited information is available about HIV molecular epidemiology and prevalence of primary drug resistance.
OBJECTIVES: To investigate the molecular epidemiology of HIV-1 in Florianópolis and to describe the prevalence of primary HIV-1 drug resistance mutations (DMRs). STUDY
DESIGN: Epidemiological and clinical data from 82 untreated patients from Florianópolis (2008-2009) were analyzed. The HIV-1 subtype at envelope, protease, reverse transcriptase and integrase regions were determined by phylogenetic and bootscaning analyses and the drug resistance profile were analyzed at the Stanford HIV Drug Resistance Database.
RESULTS: The most frequent HIV-1 genetic form was subtype C (65.8%) followed by mosaics BC (18.3%), subtype B (13.4%), subtype F1 (1.2%) and BCF1 recombinant (1.2%). HIV-1 subtype C and BC recombinants were much more frequent in the heterosexual exposure category, whereas subtype B was more common in the MSM exposure category. DRMs were seen in 11% of the sequences, 2.4% of them were related to PI, 5% to NRTI, 3.6% to NNRTI and 1.2% was related to INTI.
CONCLUSIONS: The present study confirms the high prevalence of subtype C and BC recombinants in Santa Catarina State and revealed a significant difference in the subtype distribution among distinct virus exposure categories. This study also shows a relative high prevalence of protease/reverse transcriptase primary drug resistance mutations and corroborates the usefulness of the integrase inhibitors in southern Brazil.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21622023     DOI: 10.1016/j.jcv.2011.04.011

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  21 in total

1.  Analysis of transmitted resistance to raltegravir and selective pressure among HIV-1-infected patients on a failing HAART in Sao Paulo, Brazil.

Authors:  N P Mantovani; R G Azevedo; J T Rabelato; S Sanabani; R S Diaz; S V Komninakis
Journal:  J Clin Microbiol       Date:  2012-03-07       Impact factor: 5.948

2.  Frequency of transmitted drug resistance mutations among treatment-naïve HIV-1-infected individuals at a tertiary care centre in South India.

Authors:  Rajesh Kannangai; Shoba David; Vijayanand C Sundaresan; Jaiprasath Sachithanandham; Monika Mani; Ooriapadickal Cherian Abraham; Susanne Alexander Pulimood; Priscilla Rupali; Gopalan Sridharan
Journal:  Mol Diagn Ther       Date:  2015-10       Impact factor: 4.074

3.  Comprehensive Characterization of HIV-1 Molecular Epidemiology and Demographic History in the Brazilian Region Most Heavily Affected by AIDS.

Authors:  Tiago Gräf; Hegger Machado Fritsch; Rúbia Marília de Medeiros; Dennis Maletich Junqueira; Sabrina Esteves de Matos Almeida; Aguinaldo Roberto Pinto
Journal:  J Virol       Date:  2016-08-26       Impact factor: 5.103

4.  Identification of Novel Resistance-Related Polymorphisms in HIV-1 Subtype C RT Connection and RNase H Domains from Patients Under Virological Failure in Brazil.

Authors:  Maria F M Barral; Arielly K P Sousa; André F Santos; Celina M Abreu; Amilcar Tanuri; Marcelo A Soares
Journal:  AIDS Res Hum Retroviruses       Date:  2016-12-27       Impact factor: 2.205

5.  Contribution of Epidemiological Predictors in Unraveling the Phylogeographic History of HIV-1 Subtype C in Brazil.

Authors:  Tiago Gräf; Bram Vrancken; Dennis Maletich Junqueira; Rúbia Marília de Medeiros; Marc A Suchard; Philippe Lemey; Sabrina Esteves de Matos Almeida; Aguinaldo Roberto Pinto
Journal:  J Virol       Date:  2015-09-30       Impact factor: 5.103

6.  Response of simian immunodeficiency virus to the novel nucleoside reverse transcriptase inhibitor 4'-ethynyl-2-fluoro-2'-deoxyadenosine in vitro and in vivo.

Authors:  Michael Murphey-Corb; Premeela Rajakumar; Heather Michael; Julia Nyaundi; Peter J Didier; Aaron B Reeve; Hiroaki Mitsuya; Stefan G Sarafianos; Michael A Parniak
Journal:  Antimicrob Agents Chemother       Date:  2012-06-19       Impact factor: 5.191

7.  Temporal dynamics of HIV-1 circulating subtypes in distinct exposure categories in southern Brazil.

Authors:  Sabrina Em Almeida; Rubia M de Medeiros; Dennis M Junqueira; Tiago Gräf; Caroline P B Passaes; Gonzalo Bello; Mariza G Morgado; Monick L Guimarães
Journal:  Virol J       Date:  2012-12-12       Impact factor: 4.099

8.  Phylogeographic analysis of HIV-1 subtype C dissemination in Southern Brazil.

Authors:  Gonzalo Bello; Paolo M de A Zanotto; Atila Iamarino; Tiago Gräf; Aguinaldo R Pinto; José C Couto-Fernandez; Mariza G Morgado
Journal:  PLoS One       Date:  2012-04-18       Impact factor: 3.240

9.  Transmitted Drug Resistance among People Living with HIV/Aids at Major Cities of Sao Paulo State, Brazil.

Authors:  Joao Leandro Paula Ferreira; Rosangela Rodrigues; Andre Minhoto Lança; Valeria Correia de Almeida; Simone Queiroz Rocha; Taisa Grotta Ragazzo; Denise Lotufo Estevam; Luis Fernando de Macedo Brigido
Journal:  Adv Virol       Date:  2013-01-15

10.  HIV behind bars: human immunodeficiency virus cluster analysis and drug resistance in a reference correctional unit from southern Brazil.

Authors:  Isabel M Prellwitz; Brunna M Alves; Maria Letícia R Ikeda; Daniele Kuhleis; Pedro D Picon; Carla A Jarczewski; Marta R Osório; Alexandra Sánchez; Héctor N Seuánez; Bernard Larouzé; Marcelo A Soares; Esmeralda A Soares
Journal:  PLoS One       Date:  2013-07-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.